Hemophilia Investor Event
Sanofi a eu le plaisir de convier investisseurs et analystes à participer à notre Hemophilia Investor Event qui a eu lieu en personne à ExCel Londres le mercredi 13 juillet 2022. (2:00pm GMT / 15h00 CET / 9:00am EST)
Avec
Dietmar Berger, MD PhD
Global Head of Development, CMO
Bill Sibold
Executive Vice President Specialty Care; President, Sanofi North America
Guy Young, MD
Director, Hemostasis and Thrombosis Center at Children's Hospital Los Angeles
Angela Weyand, MD
Assistant Professor at Michigan Medicine